Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
about
A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxisTrastuzumab-containing regimens for metastatic breast cancerTrastuzumab containing regimens for early breast cancerTrastuzumab containing regimens for early breast cancerTrastuzumab containing regimens for metastatic breast cancerThe GLI-Kruppel family of human genesIdentification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each otherLigand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor familyIdentification of heregulin, a specific activator of p185erbB2Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumorsFailure of spinal cord oligodendrocyte development in mice lacking neuregulinHuman proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligandMolecular cloning and expression of an additional epidermal growth factor receptor-related geneOncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gammaHumanization of an anti-p185HER2 antibody for human cancer therapyIsolation of an additional member of the fibroblast growth factor receptor family, FGFR-3Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosoureaA differential PCR assay for the detection of c-erbB 2 amplification used in a prospective study of breast cancerHuman c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptorlike moleculeInhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigenCognate homeo-box loci mapped on homologous human and mouse chromosomesSomatic mutations of the epidermal growth factor receptor and non-small-cell lung cancerBIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsMedullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behaviorPlexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityPolysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsNew advances in targeted gastric cancer treatmentChromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomasHER2 as a therapeutic target in head and neck squamous cell carcinomaRNA-Seq reveals 10 novel promising candidate genes affecting milk protein concentration in the Chinese Holstein population.The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitorA differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signalingComparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic useThe N-terminal region of NTAK/neuregulin-2 isoforms has an inhibitory activity on angiogenesisAnalysis of Her2/neu membrane protein clusters in different types of breast cancer cells using localization microscopy
P2860
Q22253346-9F373698-B842-482E-AFCB-ED4345DF2EB3Q24194019-06D2A540-B4F1-4D3D-BE5D-EFF3AC251F5AQ24200192-34C10F30-CC0C-4CDE-B6FA-EC8E15DD3D79Q24244420-E93655A4-3B75-4CB6-B9A6-8E068F988BE6Q24244565-E852A44D-D505-4A34-8C78-8039473A74D6Q24293272-7317CCAE-8879-44F9-977F-225696540BFAQ24294014-3BF2F210-8E6C-45D6-8110-132FC1A6A235Q24314750-C9041CA3-9B38-409D-8B21-D4B1487CB071Q24338146-5F9536EC-F089-428B-9DDC-48020B54362DQ24339400-4F1237D4-C7B4-444B-8EF6-5499FF93C3F9Q24554441-1B0B3999-832A-452B-94BD-760AAA5C921BQ24555963-37D6AA98-50F2-488B-91EA-C7CE90067E96Q24557757-E1414F6D-5D0D-4155-A7F3-11F03E1EA4CAQ24561375-FF13D671-D6F6-4171-BB06-51E5A5CE4A2EQ24561842-CDF7BB91-84E5-4A3C-8F0E-55BA249E5CD0Q24564164-8B38CDAD-500E-4B0F-A0B6-4B97796814FAQ24594880-FEA56503-3F53-4A3B-B84E-26D94A4B3845Q24609066-5419FC5B-651D-4C32-8D2C-33206969D461Q24613757-54CCC0F5-FB81-4345-884C-7396A816401EQ24628627-3A3C17CE-68C7-4455-B96D-5EC558B68F5EQ24628673-2734BBFA-24F7-42BF-9D8A-D313EE0306CDQ24648133-975E9BFC-7EC0-4C38-B1E8-E5E9D0EAD366Q24649935-7B6F1E63-4A86-4BD6-A2E2-6E0A0B19BCFBQ24676403-A7044CA5-9D9D-4948-A201-2D96FE20381BQ24676439-63508F63-4F59-4EEB-BB3E-8C340DF62759Q24679438-567A682C-E6A3-4E60-832E-8E10455EF395Q24797806-E8AC911C-EE53-4A04-9FA8-54C388CA42D9Q24803054-7B4FC118-2798-4F61-B909-A8169634AF0DQ24810669-74DCF4B5-52B8-4539-991D-D718D5BC8F04Q24813543-A93B5974-738E-4DAA-BC1D-897EE94570A0Q25257668-E525E694-804E-4BB2-9722-2BE26EB013C9Q26738548-80B73578-D698-4A9D-957B-94C90C0AE6E3Q26865068-2A688BAD-D103-4185-A2A8-07C1D0FD8DBDQ27026178-704295BD-0B6B-41EF-A808-47452B2BA5CDQ27349350-B2673768-EB7D-4AE0-99DE-E50637D1783CQ28118420-2A74DC0F-A756-498F-8A45-B6DB9841F368Q28139198-5699CB5A-FB0C-4B29-8BD1-1917B2B4832AQ28140514-9C64FBD7-B61B-41AD-AAF4-6AB5D1B584A5Q28238593-B581144B-FE5D-481A-A427-759469E3602DQ28299542-9A750DE2-094A-4500-9730-B5548DB4D163
P2860
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Tyrosine kinase receptor with ...... mal location with neu oncogene
@ast
Tyrosine kinase receptor with ...... mal location with neu oncogene
@en
Tyrosine kinase receptor with ...... mal location with neu oncogene
@nl
type
label
Tyrosine kinase receptor with ...... mal location with neu oncogene
@ast
Tyrosine kinase receptor with ...... mal location with neu oncogene
@en
Tyrosine kinase receptor with ...... mal location with neu oncogene
@nl
prefLabel
Tyrosine kinase receptor with ...... mal location with neu oncogene
@ast
Tyrosine kinase receptor with ...... mal location with neu oncogene
@en
Tyrosine kinase receptor with ...... mal location with neu oncogene
@nl
P2093
P3181
P356
P1433
P1476
Tyrosine kinase receptor with ...... mal location with neu oncogene
@en
P2093
J Schlessinger
L Coussens
T A Libermann
T L Yang-Feng
P304
P3181
P356
10.1126/SCIENCE.2999974
P407
P577
1985-12-06T00:00:00Z